PharmiWeb5h
Diabetes Drugs Market Forecasted to Reach US$ 177.74 Billion by 2034, Expanding at a CAGR of 7.7%
The global Diabetes Drugs Market size was valued at USD 84.65 billion in 2024 and is expected to be worth around USD 177.74 ...
Health and Me on MSN9h
GLP-1 Drugs Could Be Used To Treat Chronic Kidney Disease
A latest research led by Dr Shuyao Zhang, an assistant professor of internal medicine at UT Southwestern in Dallas reveal the ...
Too Old to Operate14h
Age Differences Seen in Efficacy of Type 2 Diabetes Treatments
Age differences are seen in the efficacy of treatments for type 2 diabetes, according to a study published online Feb. 3 in ...
Healio21h
SGLT2s, GLP-1s reduce risk for COPD exacerbations
Sodium-glucose cotransporter 2, or SGLT2, inhibitors and glucagon-like peptide-1 receptor agonists lowered the risk for COPD exacerbation in adults with the disease and type 2 diabetes, researchers ...